Understanding How Your Body Responds to Filarial Infection
Part of Infections, Skin clinical trials.
This study looks at how the body's immune system reacts to filarial infections—parasitic worms that affect millions worldwide. Researchers will observe your infection and response to treatment to better understand the disease and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 3 and 100 years old
- Clinical signs or symptoms suggesting a filarial infection (parasitic worm infection)
- Have a primary doctor or healthcare provider outside of NIH who can provide ongoing care
- Able to understand and agree to participate in the study (or have a parent/guardian consent if under 18)
- If pregnant or nursing, you can enroll but will not receive treatment medications during pregnancy or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new rapid diagnostic test that aims to help eliminate onchocerciasis (river blindness). The test will be checked in people with different types of filarial worm infections (or no infection) to see how well it can tell them apart.
This study evaluates and treats patients who may have a parasitic infection (an infection caused by parasites—tiny organisms that live in or on the body). Researchers will monitor your condition and provide care to help you get better.
This trial studies people with Leishmania infections (a parasitic disease often from sand fly bites). Researchers aim to better understand and treat the infection, and you may benefit from expert care.
This study follows patients who have been treated for neurocysticercosis—a brain infection caused by a parasite—to learn how they recover over time and what long-term effects they experience. By joining, you'll help doctors better understand this condition and improve care for future patients.
This study looks at immune system differences that can make some people get unusual or frequent fungal (fungus) infections. It may help researchers better understand these conditions, and you may be asked to store blood for future research.
This trial helps doctors evaluate possible infection or inflammation and decide on the best management plan. You may be able to receive specialized care at the NIH if the study team thinks your situation fits.
Hear when a new Onchocerciasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.